Sjö Diagnostic Test

Uncover a potential systemic cause of dry eye before it takes hold.

Sjö is a diagnostic test that combines traditional and novel, proprietary biomarkers to create an advanced diagnostic panel for the early detection of Sjögren’s syndrome in your patients.

The early symptoms of Sjögren’s syndrome commonly present as routine dry eye.1
Sjögren’s syndrome affects up to 4 million people in the U.S.; many of whom are undiagnosed.1,2


Sjo Interactive Interpretation Tool

Your patients’ dry eye symptoms may be rooted in a progressive autoimmune disease.

  • Sjögren’s syndrome is a serious autoimmune disease that causes damage to the exocrine glands, which are responsible for producing moisture1,2,3
  • There is an average delay of several years in receiving an accurate diagnosis2
  • Early diagnosis can result in patients being monitored for organ-specific manifestations, general symptoms, associated autoimmune diseases and malignancies.

For more information on the Sjö Diagnostic test:
Call: 855-696-4269
Email: support@bldiagnostics.com 

You may be positioned to help detect Sjögren’s syndrome earlier in your patients with the Sjö diagnostic kit. 

Sjö—Early detection of Sjögren’s syndrome

  • Combines 4 traditional biomarkers with 3 novel, propriety biomarkers
  • Helps detect Sjögren’s syndrome early in its disease course
  • Offers high specificity and significantly higher sensitivity than other screening methods

Sjö combines traditional and novel, proprietary biomarkers to create an advanced diagnostic panel:



How to Use the Sjö Diagnostic Test - Video



Sjö : Additional information


1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275-1284.
2. Sjögren’s Syndrome Foundation. 2017. Available at http://www.sjogrens.org/home/about-sjogrens/diagnosis. Accessed April, 2017.
3. Martin-Martin LS, Massafra U, Migliore A. Sjögren’s syndrome: an under-diagnosed disorder. CLI. May 2004.
4. Liew M, Zhang M, Kim E, et al. Prevalence and predictors of Sjögren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96:1498-1503.
5. Shen L, Suresh L, Lindemann M, et al. Novel autoantibodies in Sjögren’s syndrome. Clin Immunol. 2012;145:251-255.


SJO.0036.USA.17